Breakthrough in A3SMO® – Artificial Amino Acid-based Small Molecule therapeutics
Investors @ Partners
Ladon Therapeutics brings together breakthrough peptide chemistry and a state of the art diagnostic laboratory from gene expression profiling to in vivo disease models to characterize, test and evaluate ixPeptide® drug candidates.